HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel,...
Hence then, the article about akeso highlights collaboration between its partner summit therapeutics and pfizer to explore ivonescimab in combination with pfizer s adcs was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs )
Also on site :
- Russian hockey legend Ovechkin refuses to wear LGBT tape
- After the Fire, Hope Valley Faces Its First Reckoning in 'When Calls the Heart' Season 13 Episode 3
- Simone Biles Stuns in Jonathan Owens-Inspired Outfit for NFL Playoff Game